- Home
- NFGC vs IART Comparison
NFGC vs IART Comparison
Compare NFGC & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NFGC | IART |
|---|---|---|
| Founded | 2016 | 1989 |
| Country | Canada | United States |
| Employees | N/A | 4427 |
| Industry | Precious Metals | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 760.5M | 1.2B |
| IPO Year | 2021 | 1996 |
Fundamental Metrics
Financial Performance| Metric | NFGC | IART |
|---|---|---|
| Price | $1.91 | $15.11 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $14.33 |
| AVG Volume (30 Days) | ★ 1.4M | 1.1M |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $3,542.00 | $4.39 |
| Revenue Next Year | $118.57 | $3.40 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.39 | $8.70 |
| 52 Week High | $3.59 | $16.42 |
Technical Indicators
Market Signals| Indicator | NFGC | IART |
|---|---|---|
| Relative Strength Index (RSI) | 40.68 | 70.06 |
| Support Level | $1.85 | $12.64 |
| Resistance Level | $2.14 | $16.35 |
| Average True Range (ATR) | 0.12 | 0.91 |
| MACD | -0.02 | 0.11 |
| Stochastic Oscillator | 4.94 | 90.11 |
Price Performance
Historical ComparisonAbout NFGC New Found Gold Corp
New Found Gold Corp is a mineral exploration company engaged in the acquisition, exploration and evaluation of resource properties with a focus on gold properties located in the Provinces of Newfoundland and Labrador and Ontario, Canada. The Companies exploration is focused on discovering and delineating gold resources. The Company has one material property: the Queensway Project located in Newfoundland, Canada (the Queensway Project).
About IART Integra LifeSciences Holdings Corporation
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.